Skip to content

Menu

GammaTile Therapy
Clinical Resources
- Roads
- Gestalt
GammaTile Centers
Recruiting Trials
Tumor Bed Calculator
News
Events
Contact

Category: Press Releases

GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions

GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131

GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.

GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors

GT Medical Technologies, Inc. Names Per Langoe As CEO

GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.

GT Medical Technologies, Inc. Presents Use of GammaTile Therapy is Increasing in Time Across Several Brain Tumor Types at the 28th Annual Scientific Meeting and Education Day at the Society of Neuro-Oncology (SNO)

GT Medical Technologies, Inc. Announces Ty Atteberry

As Vice President of Sales

GT Medical Technologies, Inc. Nominated for Prix Galien USA 2023 Award by Galien Foundation in Best Medical Device Category for Company’s

GT Medical Technologies, Inc.’ GammaTile® Therapy Awarded 2023 Most Promising New Product of the Year

Posts navigation

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS

GammaTile Therapy
Clinical Resources
GammaTile Centers
News
Events
About Us
Contact
Ordering
Returns

©2024 GT Medical Technologies, Inc. | All rights reserved | Instructions for Use | Privacy Policy | Terms of Use

We use cookies to enhance your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.Accept Privacy policy